The XXV EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2018) is organised by the Section for Medicinal Chemistry of the Slovenian Pharmaceutical Society (SFD), on behalf of the European Federation for Medicinal Chemistry (EFMC).
The symposium will take place in Ljubljana from September 2-6, 2018 and we are pleased to confirm that Asynt will be there to support the event. You can see more information on the event website HERE. The full programme is now available online here: https://www.efmc-ismc.org/programme
The 2018 edition will continue the tradition established by these biennial symposia of covering drug discovery advances in major therapeutic areas, including the treatment of inflammatory and autoimmune diseases, infectious diseases including fungal infections, cardiometabolic diseases, neurodegenerative diseases and oncology. EFMC-ISMC 2018 will present the most recent advances in up-to-date topics like protein degradation, STING pathway, kinetics and pharmacokinetics of drug binding and PET imaging, and will tackle some out-of-the-box areas of Medicinal Chemistry including carbohydrate-based vaccines and new chemical modalities, while Chemical Biology approaches to target identification will cover the interfaces between chemistry, biology and experimental medicine. Particular emphasis will be put on first time disclosures, recent highlights in medicinal chemistry, and the impact of artificial intelligence in drug discovery.
Dr Kerry Elgie and Dr Arran Solomonsz will be on hand to answer any questions you have regarding the exciting and innovative laboratory tools we have available and give you the opportunity to take a closer look at recent additions to the portfolio such as the DrySyn OCTO and DrySyn Spiral Evaporator. We will also have examples of our High Pressure Reactors, ReactoMate, DrySyn heating and cooling block system and CondenSyn waterless air condensers available to examine of course!
